Endometrial ablation

Endometrial ablation
Intervention

Hysteroscopic endometrial ablation
ICD-9-CM 68.23

Endometrial ablation is a medical procedure that is used to remove (ablate) or destroy the endometrial lining of a uterus. Endometrial ablation should never be performed on women who wish to have children[1] for the mother and child. . This technique is most often employed for people who suffer from excessive or prolonged bleeding during their menstrual cycle but cannot or do not wish to undergo a hysterectomy. The procedure is most commonly done on an outpatient basis. Placenta accreta may occur if the patient becomes pregnant after endometrial ablation, so birth control is recommended. However, heavy menstrual bleeding is most commonly due to dysfunctional uterine bleeding or adenomyosis.

Endomatrial ablation is normally conducted after treatment with hormones, such as norethisterone or Lupron.[2]

Sterilization

Women who wish to be come pregnant should not undergo endometrial ablation; pregnancy is rare (less than 2 per cent) and can have mortal risks[3] for the mother and child.

Effectiveness

Approximately 78% of those who undergo this procedure will have reduced menstrual bleeding. Of those, approximately 36% will stop having periods altogether. However, a second procedure or a hysterectomy will be required in approximately 22% of cases.

Risks

Although uncommon, the procedure can have serious complications including:

Procedure

A number of competing procedures are available.[4]

Older methods utilize hysteroscopy to insert instruments into the uterus to destroy the lining under vision using laser or electric current in a small loop. Another system introduces a radio-frequency rod that emits energy to destroy the uterine lining.

The procedure is done while the patient is either under local anesthesia, or, if necessary, general or spinal anesthesia. The recovery period can be from one day up to 2 weeks.

After the procedure, the endometrium heals by scarring, reducing or removing the possibility of future uterine bleeding. The patient may develop amenorrhea, however hormonal functioning will remain unaffected.

See also

References

  1. [Serious and deadly complications from pregnancy after endometrial ablation: Two case reports and review of the literature, P.-Y. Laberge, Department of Obstetrics and Gynaecology, CHUL, Laval University, 2705, boulevard Laurier, S-768 Quebec City, G1V 4G2 Quebec, Canada http://www.em-consulte.com/en/article/256077]
  2. [Endometrial Ablation, Website of Johns Hopkins University https://www.hopkinsmedicine.org/healthlibrary/test_procedures/gynecology/endometrial_ablation_92,P07774/]
  3. [Serious and deadly complications from pregnancy after endometrial ablation: Two case reports and review of the literature, P.-Y. Laberge, Department of Obstetrics and Gynaecology, CHUL, Laval University, 2705, boulevard Laurier, S-768 Quebec City, G1V 4G2 Quebec, Canada http://www.em-consulte.com/en/article/256077]
  4. http://www.bostonscientific.com/templatedata/imports/collateral/Gynecology/oth_articleCarver_The%20Female%20Patient_01_gy_us.pdf
  5. Hysteroscopic Surgery, by King’s College Hospital. August 2013
  6. Cooper, K. G.; Bain, C.; Parkin, D. E. (1999). "Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: A randomised trial". The Lancet. 354 (9193): 1859–1863. doi:10.1016/S0140-6736(99)04101-X. PMID 10584722.
  7. Page 122 in Desai (January 2002). Gynecology Endoscopic Surgery: Current Concepts. Jaypee Brothers Publishers. ISBN 978-81-7179-937-4.
  8. "HTA Ablation". Centre for Women's Health - Wichita. Retrieved 15 September 2014.
  9. NovaSure. Instructions for use. 2004 Cytec Corporation.
  10. Gynecare Thermachoice III. Instructions for use. 2008 ETHICON, Inc. a Johnson & Johnson Company.
This article is issued from Wikipedia - version of the 11/29/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.